https://www.newswire.ca/news-releases/synageva-biopharma-starts-rolling-submission-of-a-biologics-license-application-to-the-fda-for-sebelipase-alfa-522291461.html
Synageva BioPharma Starts Rolling Submission Of A Biologics License Application To The FDA For...
/CNW/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, announced today...